↓ Skip to main content

Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival—a substudy of the MIMOSA trial

Overview of attention for article published in Cancer Immunology, Immunotherapy, June 2014
Altmetric Badge

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
26 Mendeley